CtrlK
BlogDocsLog inGet started
Tessl Logo

blockbuster-therapy-predictor

Predict which early-stage biotechnology platforms (PROTAC, mRNA, gene editing, etc.) have the highest potential to become blockbuster therapies. Analyzes clinical trial progression, patent landscape maturity, and venture capital funding trends to generate investment and R&D prioritization scores. Trigger when: User asks about technology investment potential, platform selection, or therapeutic modality comparison.

Install with Tessl CLI

npx tessl i github:aipoch/medical-research-skills --skill blockbuster-therapy-predictor
What are skills?

79

Does it follow best practices?

Validation for skill structure

SKILL.md
Review
Evals

Blockbuster Therapy Predictor

Comprehensive analytics tool for forecasting breakthrough therapeutic technologies by integrating multi-dimensional data sources including clinical development pipelines, intellectual property landscapes, and capital market indicators.

Features

  • Multi-Source Data Integration: Aggregates clinical trials, patents, and funding data
  • Predictive Scoring: Calculates Blockbuster Index combining maturity, market potential, and momentum
  • Technology Landscape Mapping: Tracks 10+ emerging therapeutic platforms
  • Investment Intelligence: Provides data-driven R&D and investment recommendations
  • Trend Analysis: Identifies acceleration patterns and inflection points

Usage

Basic Usage

# Run complete analysis with all technologies
python scripts/main.py

# Analyze specific technologies
python scripts/main.py --tech PROTAC,mRNA,CRISPR

# Output in JSON format
python scripts/main.py --output json

Parameters

ParameterTypeDefaultRequiredDescription
--modestrfullNoAnalysis mode: full or quick
--techstrNoneNoComma-separated list of technologies to analyze
--outputstrconsoleNoOutput format: console or json
--thresholdfloat0NoMinimum blockbuster index threshold (0-100)
--savestrNoneNoSave report to file path

Advanced Usage

# Analyze high-potential technologies only (index ≥70)
python scripts/main.py \
  --threshold 70 \
  --output json \
  --save high_potential_report.json

# Quick analysis of specific platforms
python scripts/main.py \
  --mode quick \
  --tech CAR-T,ADC,Bispecific \
  --output console

Output

Console Output

🏆 BLOCKBUSTER THERAPY PREDICTOR Report
Generated: 2026-02-15 10:30:00
Technologies analyzed: 10

📊 Technology Rankings
Rank  Technology       Blockbuster Index    Maturity    Market Potential    Momentum    Recommendation
🥇 1   mRNA             85.2                 78.5        92.1                88.0        Strongly Recommended
🥈 2   CAR-T            82.3                 85.2        78.5                75.0        Strongly Recommended
🥉 3   CRISPR           79.8                 72.3        88.2                68.0        Recommended

JSON Output Structure

{
  "generated_at": "2026-02-15T10:30:00",
  "total_routes": 10,
  "rankings": [
    {
      "rank": 1,
      "tech_name": "mRNA",
      "blockbuster_index": 85.2,
      "maturity_score": 78.5,
      "market_potential_score": 92.1,
      "momentum_score": 88.0,
      "recommendation": "Strongly Recommended",
      "key_drivers": ["Multiple Phase III trials", "Rapid patent growth"],
      "risk_factors": ["Regulatory uncertainties"],
      "timeline_prediction": "First product expected in 2-4 years"
    }
  ]
}

Scoring Methodology

Blockbuster Index Formula

Blockbuster Index = (Market Potential × 0.5) + (Maturity × 0.3) + (Momentum × 0.2)

Component Scores

ComponentWeightFactors
Market Potential50%Market size, unmet need, competition
Maturity30%Clinical stage, patent depth, funding stage
Momentum20%Patent growth, funding activity, clinical progress

Investment Recommendation Thresholds

Blockbuster IndexRecommendationAction
≥ 80Strongly RecommendedPrioritize R&D investment
60-79RecommendedActive monitoring and early partnerships
40-59WatchMonitor milestones; reassess in 6-12 months
< 40CautiousMinimal investment; consider divestment

Supported Technologies

TechnologyCategoryDescription
PROTACProtein DegradationProteolysis Targeting Chimera
mRNANucleic Acid DrugsMessenger RNA therapy platform
CRISPRGene EditingCRISPR-Cas gene editing technology
CAR-TCell TherapyChimeric Antigen Receptor T-cell therapy
BispecificAntibody DrugsBispecific antibody technology
ADCAntibody DrugsAntibody-Drug Conjugate
RNAiNucleic Acid DrugsRNA interference therapy
Gene TherapyGene TherapyAAV vector gene therapy
AllogeneicCell TherapyUniversal/Allogeneic cell therapy
Cell TherapyCell TherapyGeneral cell therapy platform

Technical Difficulty: MEDIUM

⚠️ AI自主验收状态: 需人工检查

This skill requires:

  • Python 3.8+ environment
  • Basic understanding of biotech investment analysis
  • Access to clinical trial, patent, and funding databases (optional)

Dependencies

Required Python Packages

pip install -r requirements.txt

Requirements File

dataclasses
enum

Risk Assessment

Risk IndicatorAssessmentLevel
Code ExecutionPython scripts executed locallyMedium
Network AccessNo external API calls in mock modeLow
File System AccessRead/write report files onlyLow
Instruction TamperingStandard prompt guidelinesLow
Data ExposureOutput files saved to workspaceLow

Security Checklist

  • No hardcoded credentials or API keys
  • No unauthorized file system access (../)
  • Output does not expose sensitive information
  • Prompt injection protections in place
  • Input file paths validated (no ../ traversal)
  • Output directory restricted to workspace
  • Script execution in sandboxed environment
  • Error messages sanitized (no stack traces exposed)
  • Dependencies audited

Prerequisites

# Python dependencies
pip install -r requirements.txt

Evaluation Criteria

Success Metrics

  • Successfully executes main functionality
  • Output meets quality standards
  • Handles edge cases gracefully
  • Performance is acceptable

Test Cases

  1. Basic Functionality: Run without arguments → Expected output with all technologies
  2. Technology Filter: Use --tech flag → Only specified technologies analyzed
  3. JSON Output: Use --output json → Valid JSON format output
  4. Threshold Filter: Use --threshold 70 → Only technologies with index ≥70 shown

Lifecycle Status

  • Current Stage: Draft
  • Next Review Date: 2026-03-15
  • Known Issues: None
  • Planned Improvements:
    • Integration with real-time data APIs
    • Additional technology platforms
    • Enhanced visualization capabilities

References

See references/ for:

  • Historical blockbuster case studies
  • Clinical trial data sources
  • Patent analysis methodologies
  • Investment scoring frameworks

Limitations

  • Data Source: Uses mock data for demonstration; real-time data integration required for production use
  • Prediction Accuracy: Model provides indicative scores; not investment advice
  • Technology Coverage: Limited to pre-configured technology platforms
  • Market Dynamics: Cannot predict black swan events or regulatory changes
  • Regional Bias: Data primarily focused on US/EU markets

⚠️ DISCLAIMER: This tool provides quantitative analysis for decision support only. All investment and R&D decisions should incorporate qualitative domain expertise, regulatory consultation, and comprehensive due diligence. Past performance of historical blockbusters does not guarantee future success of emerging technologies.

Repository
aipoch/medical-research-skills
Last updated
Created

Is this your skill?

If you maintain this skill, you can claim it as your own. Once claimed, you can manage eval scenarios, bundle related skills, attach documentation or rules, and ensure cross-agent compatibility.